Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Kemps PG, Woei-A-Jin FJSH, Schöffski P, Tousseyn T, Vanden Bempt I, Meyer-Wentrup FAG, Dors N, van Eijkelenburg NKA, Scheijde-Vermeulen MA, Jazet IM, Limper M, Jak M, Verdijk RM, Donker ML, de Jonge NA, van Noesel CJM, Hebeda KM, van Dorp S, Tonino SH, van Laar JAM, van den Bos C, van Halteren AGS; HOVON Histiocytic and Lymphocytic Diseases Working Group.
Kemps PG, et al. Among authors: dors n.
Blood Neoplasia. 2024 Jun 10;1(3):100023. doi: 10.1016/j.bneo.2024.100023. eCollection 2024 Sep.
Blood Neoplasia. 2024.
PMID: 40453055
Free PMC article.